Erythropoietin, aka EPO, is best known for its role in the Lance Armstrong cheating scandal. But EPO is also the star of ...

A paper proposing NIH reforms is circulating in academic circles and within the agency as scientists search for hints of its ...

If we cut or limit funding for curiosity-driven research, we risk shutting down the pipeline of future innovation,” writes ...

FDA and CDC cuts will only exacerbate problems with tobacco regulation and enforcement, say public health experts ...

Health Secretary Robert F. Kennedy Jr. took office promising ‘radical transparency.’ His plan to reshape the agency is indeed ...

The Trump administration and health secretary Robert F. Kennedy Jr. are ushering in an extraordinary reshaping of health and ...

With $100 million in federal funds suddenly revoked, New York City’s acting health commissioner says defense against ...

In recording, Makary said little about specific plans for his agency or about the layoffs that have roiled his workforce.

ASPE and AHRQ are losing key research staff as part of the HHS cuts Tuesday. Current and former employees worry vital ...

A national leader in medicine with impeccable credentials, Dr. Makary is imminently qualified to lead the FDA at this ...

The suit filed Wednesday aims to restore funding and end grant cancellations, arguing they violate NIH’s science-based review ...

Some HHS officials who received layoff notices were offered the chance to instead transfer to the Indian Health Service.